stars 1 stars 2 stars 3

Vibalogics (now part of Recipharm) is a full-service CDMO offering process technical transfer, development, GMP manufacturing, testing and fill-finish services to innovators developing virotherapies. Through a comprehensive set of clinical- and commercial-enabling service offerings, we partner with our clients to support early-to-late stage success. Built on a foundation of robust industry-leading scientific expertise, quality systems and global regulatory compliance, we deliver manufactured products with a complementing customer service experience that is customer friendly, communication-forward, transparent and flexible. Service Offerings: GMP Cell Banking | GMP Viral Banking | Technical Transfer | Process & Analytical Development | GMP Drug Substance Manufacture | GMP Drug Product Manufacture | Formulation, Fill & Finish | Lot / Batch Release | Stability Studies Product Experience Includes: Live Viruses | Viral Vectors | Oncolytic Viruses | Gene Therapy | Vaccines | Adenovirus (Primate & Human) | Adeno-Associated (AAV) | Dengue | Herpes (HSV, Marek Disease, CMV) | Influenza (Flu) | Infectious Bursal Disease (IBDV) | Measles (Rubeola) | Newcastle Disease (NDV) | Poxviruses | Porcine Reproductive Respiratory Syndrome (PRRSV) | Respiratory-Syncitial Virus (RSV) | Vaccinia (VACV/MVA) | Vesicular Stomatitis Virus (VSV)

Vibalogics Questions

The Vibalogics annual revenue was $19.4 million in 2026.

32 people are employed at Vibalogics.

Vibalogics is based in Cuxhaven, Lower Saxony.

The NAICS codes for Vibalogics are [32, 3254, 325414, 541, 325, 54, 32541].

The SIC codes for Vibalogics are [28, 87, 873, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users